<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="ppub"/></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS192792</article-id><article-id pub-id-type="doi">10.1101/2023.12.13.571416</article-id><article-id pub-id-type="archive">PPR773709</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Examining the potential involvement of NONO in TDP-43 proteinopathy in <italic>Drosophila</italic></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Koch</surname><given-names>Rafael</given-names></name></contrib><contrib contrib-type="author"><name><surname>Nagoshi</surname><given-names>Emi</given-names></name><xref ref-type="corresp" rid="CR1">*</xref></contrib><aff id="A1">Department of Genetics and Evolution and Institute of Genetics and Genomics of Geneva (iGE3), University of Geneva, CH-1205 Geneva, Switzerland</aff></contrib-group><author-notes><corresp id="CR1"><label>*</label>Corresponding author: <email>Emi.Nagoshi@unige.ch</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>15</day><month>12</month><year>2023</year></pub-date><pub-date pub-type="preprint"><day>13</day><month>12</month><year>2023</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">The misfolding and aggregation of TAR DNA binding protein-43 (TDP-43), leading to the formation of cytoplasmic inclusions, emerge as a key pathological feature in a spectrum of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal lobar dementia (FTLD). TDP-43 shuttles between the nucleus and cytoplasm but forms nuclear bodies (NBs) in response to stress. These NBs partially colocalize with nuclear speckles and paraspeckles that sequester RNAs and proteins, thereby regulating many cellular functions. The laboratory of Steven Brown has recently found that the non-POU domain-containing octamer-binding protein (NONO), a component of paraspeckles, forms novel nuclear speckle-like structures in mouse cortical neurons in response to stress and sleep deprivation. These findings suggest the possibility of a functional link between NONO and TDP-43, potentially contributing to TDP-43 proteinopathy. Here, we demonstrate that loss of function in the <italic>Drosophila</italic> homolog of <italic>NONO, no on or off transient A</italic> (<italic>NonA</italic>), exacerbates pathological phenotypes caused by <italic>TDP-43</italic> gain of function, leading to locomotor defects and life span shortening. These results provide supporting evidence for the functional link between NONO and TDP-43 and lay the foundation for dissecting underlying mechanisms.</p></abstract><kwd-group><kwd>Nuclear bodies</kwd><kwd>Neurodegenerative disorders</kwd><kwd>Locomotor deficits</kwd><kwd>Lifespan</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2">TAR DNA binding protein-43 (TDP-43) is a highly conserved protein belonging to the heterogeneous nuclear ribonucleoprotein (hnRNP) family. Similar to other hnRNPs, TDP-43 contributes to various processes in nucleic acid metabolism, such as RNA splicing, mRNA stability, microRNA maturation, and transcriptional regulation (<xref ref-type="bibr" rid="R4">Buratti &amp; Baralle, 2012</xref>). The presence of cytoplasmic inclusions containing TDP-43 has been identified in the nervous tissues of patients affected by a broad range of neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS), frontotemporal lobar dementia (FTLD), Alzheimer’s disease (AD) (<xref ref-type="bibr" rid="R15">Neumann <italic>et al</italic>., 2006</xref>). Growing evidence supports TDP-43 misfolding as a key pathogenic factor in these disorders, leading to their collective designation as TDP-43 proteinopathy (<xref ref-type="bibr" rid="R5">de Boer <italic>et al</italic>., 2021</xref>). Despite the large body of studies, however, the pathogenic mechanism underlying TDP-43 proteinopathy remains incompletely understood.</p><p id="P3">TDP-43 shuttles between the nucleus and cytoplasm, predominantly localized in the nucleus under non-stress conditions. Recent studies have shown that, in response to stress, TDP-43 forms nuclear bodies (NB), the membraneless nuclear structures concentrating nuclear proteins, RNAs, and RNPs. These TDP-43 NBs partially colocalize with nuclear speckles and paraspeckles (<xref ref-type="bibr" rid="R7">Dykstra &amp; Barmada, 2023</xref>). Although the native function of nuclear bodies remains elusive, the dynamic formation of TDP-43 NB formation in response to stress suggests its stress-mitigating role. The formation of NBs can alleviate the generation of cytoplasmic inclusions, and dysfunction in this process may contribute to the development of neurodegenerative disorders (<xref ref-type="bibr" rid="R18">Wang <italic>et al</italic>., 2020</xref>).</p><p id="P4">Paraspeckles are formed by the interaction between the long non-coding RNA <italic>NEAT1</italic> (nuclear-enriched abundant transcript 1) and the members of the <italic>Drosophila</italic> Behavior Human Splicing (DBHS) family of proteins, namely P54NRB/non-POU domain-containing octamer-binding protein (NONO), splicing factor proline-glutamine rich (PSPC1), and PSF/SFPQ (<xref ref-type="bibr" rid="R9">Fox <italic>et al</italic>., 2018</xref>). Paraspeckles sequester proteins and RNAs, thereby regulating many cellular functions and cellular differentiation (<xref ref-type="bibr" rid="R19">Wang &amp; Chen, 2020</xref>). A component of paraspeckle NONO interacts with and modulates the activities of Period (PER) proteins, the transcriptional repressors constituting a negative feedback loop of the circadian clocks. Reduction in NONO levels therefore impairs circadian gene expression in mammalian cells (<xref ref-type="bibr" rid="R3">Brown <italic>et al</italic>., 2005</xref>). The <italic>Drosophila</italic> homolog of NONO, encoded by the <italic>no on or off transient A</italic> (<italic>nonA</italic>) has a parallel role in the <italic>Drosophila</italic> circadian clock, regulating circadian gene expression and locomotor behavior through interacting with the circadian transcriptional activator CLOCK (<xref ref-type="bibr" rid="R3">Brown <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="R14">Luo <italic>et al</italic>., 2018</xref>). While NONO regulates the circadian clockwork, it also modulates the outputs of circadian clocks in various tissues in a context-dependent manner, such as circadian-gating of cell cycle and wound healing (<xref ref-type="bibr" rid="R11">Kowalska <italic>et al</italic>., 2013</xref>) and post-transcriptional regulation of feeding/fasting cycle-dependent gene expression in the liver (<xref ref-type="bibr" rid="R1">Benegiamo <italic>et al</italic>., 2018</xref>).</p><p id="P5">Interestingly, NONO forms speckle-like structures in the nuclei, which are likely distinct from paraspeckles, in the hepatocytes upon feeding (<xref ref-type="bibr" rid="R1">Benegiamo <italic>et al</italic>., 2018</xref>). Furthermore, the laboratory of Steven Brown found that NONO forms these novel nuclear speckles in mouse cortical neurons in response to excitotoxic stress or sleep deprivation and facilitates RNA processing (personal communication from Steven Brown). Considering the dynamic subcellular localization of TDP-43, these findings collectively raise an intriguing possibility that NONO and TDP-43 may functionally interact to contribute to TDP-43 proteinopathy. This study begins to address this question using <italic>Drosophila</italic>, the model organism in which the roles of NONO and TPD-43 have been successfully studied (<xref ref-type="bibr" rid="R3">Brown <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="R8">Elden <italic>et al</italic>., 2010</xref>; <xref ref-type="bibr" rid="R13">Li <italic>et al</italic>., 2010</xref>; <xref ref-type="bibr" rid="R6">Diaper <italic>et al</italic>., 2013</xref>; <xref ref-type="bibr" rid="R14">Luo <italic>et al</italic>., 2018</xref>). We show that NONO loss of function exacerbates pathological phenotypes caused by the TDP-43 gain of function, namely lifespan reduction and locomotor deficits. These results lay the foundation to further explore the functional link between NONO and TDP-43.</p></sec><sec id="S2" sec-type="materials | methods"><title>Materials and Methods</title><sec id="S3"><title>Drosophila strains</title><p id="P6">Flies were kept on standard corn meal/molasses food at 25°C in a 12h/12h light-dark (LD) regime. <italic>elav-GAL4</italic> is described previously (<xref ref-type="bibr" rid="R12">Kozlov <italic>et al</italic>., 2020</xref>). The following stocks were obtained from the Bloomington <italic>Drosophila</italic> Stock Center: <italic>UAS-hTDP-43</italic> (RRID:BDSC_79587), <italic>nonA</italic> RNAi 1 (TRiP#HMC03675, RRID:BDSC_52933), <italic>nonA</italic> RNAi 2 (TRiP#HMJ23111, RRID:BDSC_61279), <italic>UAS-nonA RNAi</italic> TRiP# HMC04383 (RRID:BDSC_56944), <italic>D42-GAL4</italic> (RRID:BDSC_8816), <italic>GMR-Gal4</italic> (RRID:BDSC_1104), <italic>GMR57C10-GAL4</italic> (RRID:BDSC_39171), <italic>tubulin-Gal4</italic> (RRID:BDSC_5138), and <italic>UAS-mCD8::GFP</italic> (RRID:BDSC_32185). <italic>UAS-nonA RNAi</italic> GD26411 was obtained from the Vienna Drosophila Resource Center (VDRC).</p></sec><sec id="S4"><title>Climbing assay</title><p id="P7">Climbing assays were performed as described previously (<xref ref-type="bibr" rid="R2">Bou Dib <italic>et al</italic>., 2014</xref>) with minor modifications. Flies were grouped into ~20 individuals and assessed groupwise from day 1 to 21 of age, every 7 days. Dead flies were not replaced. On the day of the assay, flies were transferred into graduated 100 ml measuring cylinders divided into 5 equally spaced zones. After a 1-h recovery from mild CO<sub>2</sub> anesthesia, flies were tested by tapping them down and then allowing them to climb for 20 seconds. Each assay was repeated twice with a 5-minute break between repeats. Climbing assays were always performed at 2 h after lights-on (ZT2) to avoid the influence of circadian behavioral rhythms.</p></sec><sec id="S5"><title>Lifespan assay</title><p id="P8">Male flies of the same genotype were kept at a density of approximately 20 per vial, containing standard corn meal/molasses food. The vials were maintained in a controlled ~ 80% humidity at 25°C and under 12h/12h LD cycles. The vials were positioned horizontally to prevent flies from sticking to the food. Flies were transferred to fresh vials every two to three days and dead flies were counted. Kaplan-Meyer survival probability curves were plotted using the GraphPad Prism software (Version 10).</p></sec><sec id="S6"><title>Statistics</title><p id="P9">Climbing data were analyzed using one-way ANOVA with Tukey’s Honest Significant Difference (HSD) test in R software. The Kaplan-Meyer estimator and survival analysis log-rank tests were performed using the Mantel-Cox approach in GraphPad Prism software (Version 10). For all experiments, the level of significance was set at p&lt;0.05.</p></sec><sec id="S7"><title>Genotypes</title><p id="P10">To control for the UAS copy number, an inert <italic>10xUAS-mCD8::GFP</italic> transgene was added when only <italic>UAS-nonA RNAi</italic> or <italic>UAS-hTDP-43</italic> was driven with the GAL4.</p><p id="P11">For climbing assay (<xref ref-type="fig" rid="F1">Figure 1</xref>): <italic>w</italic><sup><italic>1118</italic></sup>; <italic>UAS-hTDP-43/+. w</italic><sup><italic>1118</italic></sup>; <italic>+; D42-GAL4. w</italic><sup><italic>1118</italic></sup>; <italic>UAS-hTDP-43/+; UAS-mCD8::GFP/D42-GAL4. w</italic><sup><italic>1118</italic></sup>; <italic>UAS-RNAi 1/+; UAS-mCD8::GFP/D42-GAL4. w</italic><sup><italic>1118</italic></sup>; <italic>UAS-RNAi 2/+; UAS-mCD8::GFP/D42-GAL4. w</italic><sup><italic>1118</italic></sup>; <italic>UAS-RNAi 1/UAS-hTDP-43; D42-GAL4/+</italic>.</p><p id="P12">For lifespan analysis (<xref ref-type="fig" rid="F2">Figure 2</xref>): <italic>w</italic><sup><italic>1118</italic></sup>; <italic>+; elav-GAL4/+. w</italic><sup><italic>1118</italic></sup>; <italic>UAS-hTDP-43/+. w</italic><sup><italic>1118</italic></sup>; <italic>UAS-RNAi 1/+. w</italic><sup><italic>1118</italic></sup>; <italic>UAS-RNAi 2/+. w</italic><sup><italic>1118</italic></sup>; <italic>UAS-hTDP-43/+; UAS-mCD8::GFP/elav-GAL4. w</italic><sup><italic>1118</italic></sup>; <italic>UAS-RNAi 1/+; UAS-mCD8::GFP/elav-GAL4. w</italic><sup><italic>1118</italic></sup>; <italic>UAS-RNAi 2/+; UAS-mCD8::GFP/elav-GAL4. w</italic><sup><italic>1118</italic></sup>; <italic>UAS-RNAi 1/UAS-hTDP-43; elav-GAL4/+. w</italic><sup><italic>1118</italic></sup>; <italic>UAS-RNAi 2/UAS-hTDP-43; elav-GAL4/+</italic>.</p><p id="P13">For eye morphology analysis (<xref ref-type="fig" rid="F3">Figure 3</xref>): <italic>w</italic><sup><italic>1118</italic></sup>; <italic>UAS-hTDP-43/GMR-GAL4; UAS-mCD8::GFP/+. w</italic><sup><italic>1118</italic></sup>; <italic>UAS-RNAi 1/GMR-GAL4; UAS-mCD8::GFP/+. w</italic><sup><italic>1118</italic></sup>; <italic>UAS-RNAi 2/GMR-GAL4; UAS-mCD8::GFP/+. w</italic><sup><italic>1118</italic></sup>; <italic>UAS-RNAi 1, UAS-hTDP-43/GMR-GAL4; UAS-mCD8::GFP/+</italic>.</p></sec></sec><sec id="S8" sec-type="results"><title>Results</title><p id="P14">Previous studies have demonstrated the pathophysiological effects of TDP-43 gain of function on cellular and organismal levels by the overexpression of human TDP-43 (hTDP-43) in flies (<xref ref-type="bibr" rid="R8">Elden <italic>et al</italic>., 2010</xref>; <xref ref-type="bibr" rid="R13">Li <italic>et al</italic>., 2010</xref>). To test if NONO influences the pathogenesis of TDP-43 proteinopathy, we wanted to combine hTDP-43 overexpression and NONO loss of function. To this end, we first assessed four independent UAS-RNAi lines (TRiP HMC03675, TRiP HMJ23111, TRiP HMC04383, and VDRC GD26411) for their efficiency in silencing endogenous <italic>nonA</italic> expression.</p><p id="P15">Ubiquitous expression of TRiP HMC03675 (referred to as RNAi 1) or TRiP HMJ23111 (referred to as RNAi 2) with <italic>tubulin-GAL4</italic> resulted in embryonic lethality, mirroring the phenotype of the <italic>nonA</italic> null allele (<xref ref-type="bibr" rid="R17">Stanewsky <italic>et al</italic>., 1993</xref>). In contrast, expressing VDRC GD26411 or TRiP HMC04383 with <italic>tubulin-GAL4</italic> did not affect viability. Driving <italic>nonA</italic> RNAi 1 with a pan-neuronal GMR57C10 driver was viable, whereas <italic>nonA</italic> RNAi 2 was mostly late pharate lethal. Expressing <italic>nonA</italic> RNAi 2 with a weaker pan-neuronal driver, <italic>elav-GAL4</italic> (<xref ref-type="bibr" rid="R12">Kozlov <italic>et al</italic>., 2020</xref>) was viable. These results indicate that <italic>nonA</italic> RNAi 1 and 2 have higher knockdown efficiency than the VDRC GD26411 and TRiP HMC04383 lines, with RNAi 2 exhibiting slightly higher efficacy than RNAi 1. Therefore, we chose to use <italic>nonA</italic> RNAi 1 and 2 in subsequent experiments.</p><p id="P16">The expression of <italic>hTDP-43</italic> in motor neurons was reported to induce progressive locomotor dysfunction (<xref ref-type="bibr" rid="R8">Elden <italic>et al</italic>., 2010</xref>; <xref ref-type="bibr" rid="R13">Li <italic>et al</italic>., 2010</xref>). We next tested if <italic>nonA</italic> RNAi modulates this phenotype by expressing <italic>hTDP-43</italic> together with <italic>nonA</italic> RNAi in motor neurons and assessing locomotion using the negative geotaxis (climbing) assays across ages. To control for the UAS copy number, an inert <italic>UAS-mCD8::GFP</italic> transgene was added when only <italic>UAS-nonA RNAi</italic> or <italic>UAS-hTDP-43</italic> was driven with the GAL4. Control flies carrying the motor neuron-specific <italic>D42-GAL4</italic> (<xref ref-type="bibr" rid="R16">Sanyal, 2009</xref>) only or UAS-<italic>hTDP-43</italic> only exhibited high levels of climbing ability at least up to age 21 days. Consistent with the previous studies, flies expressing <italic>hTDP-43</italic> with <italic>D42-GAL4</italic> displayed a significant progressive loss of climbing ability. Some <italic>hTDP-43</italic> expressing flies were unable to eclose from their pupal case and many larvae pupariated at the bottom in the food, reminiscent of the reported reduced larval motility (<xref ref-type="bibr" rid="R13">Li <italic>et al</italic>., 2010</xref>). Flies expressing <italic>nonA</italic> RNAi 1 in motor neurons were viable during the experimental period and displayed a progressive locomotor decline as compared to controls carrying only the GAL4 driver or one copy of the <italic>UAS-hTDP-43</italic> transgene. Flies expressing <italic>nonA</italic> RNAi 2 <italic>D42-GAL4</italic> were weak and showed strong locomotor impairments; the few eclosed individuals were unable to fly or climb and died before reaching day 7 (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p><p id="P17">Co-expressing <italic>hTDP-43</italic> and <italic>nonA</italic> RNAi 1 severely exacerbated locomotor deficits of flies expressing <italic>hTDP-43</italic> alone from day 1 and continuously up to at least day 21. Climbing assays of flies co-expressing <italic>hTDP-43</italic> and <italic>nonA</italic> RNAi 2 in motor neurons were not possible, as they were pharate lethal or were unable to eclose from the pupal case (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p><p id="P18">Pan-neuronal knockdown of <italic>nonA</italic> either with RNAi 1 or RNAi 2 under the control of <italic>elav-GAL4</italic> led to a reduced life span. Curiously, flies with RNAi 2 lived longer than those expressing RNAi 1, the inverse of the phenotype severity observed when they were expressed with <italic>D42-GAL4</italic>. While a previous study reported the lifespan reduction when <italic>hTDP-43</italic> was driven with <italic>elav-GAL4</italic> (<xref ref-type="bibr" rid="R8">Elden <italic>et al</italic>., 2010</xref>), we observed no differences in lifespan in <italic>elav&gt;hTDP-43</italic> flies compared to the GAL4-only or UAS-only controls. Co-expression of <italic>nonA</italic> RNAi and <italic>hTDP-43</italic> further reduced life span compared to the expression of <italic>nonA</italic> RNAi alone. (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p><p id="P19">The expression of hTDP-43 in the eye with the <italic>GMR-GAL4</italic> driver was reported to cause progressive ommatidia loss, which was visible by day 6 (<xref ref-type="bibr" rid="R8">Elden <italic>et al</italic>., 2010</xref>; <xref ref-type="bibr" rid="R13">Li <italic>et al</italic>., 2010</xref>). In the same genotype, <italic>GMR-GAL4</italic> driving <italic>hTDP-43</italic>, we did not observe any eye degeneration phenotypes at day 7. Additionally, the expression of <italic>nonA</italic> RNAi 1 or 2 individually or with <italic>hTDP-43</italic> in the eye did not visibly affect the morphology of the eye at least by day 7 (<xref ref-type="fig" rid="F3">Figure 3</xref>).</p></sec><sec id="S9" sec-type="discussion"><title>Discussion</title><p id="P20">The pathophysiology of TDP-43 proteinopathy encompasses a broad spectrum, including motor and cognitive dysfunction, as well as a reduction in lifespan (<xref ref-type="bibr" rid="R10">Kawakami <italic>et al</italic>., 2019</xref>; <xref ref-type="bibr" rid="R5">de Boer <italic>et al</italic>., 2021</xref>). Here we investigated the potential functional interaction between NONO, a multifunctional RNA-binding protein, and TDP-43, with implications for the pathophysiology of TDP-43 in <italic>Drosophila</italic>. We found that loss of <italic>nonA</italic>, the fly homolog of <italic>NONO</italic>, exacerbates locomotor deficits induced by targeted expression of hTDP-43 in motor neurons. Furthermore, the lifespan shortening induced by the pan-neuronal loss of <italic>nonA</italic> is aggravated when co-expressed with hTDP-43. Taken together, our results provide support for the hypothesis that TDP-43 and NONO functionally interact within the nervous system, contributing to the modulation of TDP-43 pathology.</p><p id="P21">While the toxicity associated with hTDP-43 expression was recapitulated in our climbing assays, we did not observe the previously reported retinal degeneration by hTDP-43 overexpression driven by <italic>GMR-GAL4</italic> (<xref ref-type="bibr" rid="R8">Elden <italic>et al</italic>., 2010</xref>; <xref ref-type="bibr" rid="R13">Li <italic>et al</italic>., 2010</xref>). A potential explanation for this discrepancy could be that our flies were assessed at a constant 25°C and not shifted to 29°C after eclosion, a method employed in a previous study to enhance GAL4 activity (<xref ref-type="bibr" rid="R8">Elden <italic>et al</italic>., 2010</xref>). Additionally, we co-expressed an inert <italic>UAS-mCD8::GFP</italic> with <italic>hTDP-43</italic> to control for UAS copy number differences between <italic>hTDP-43</italic> flies and those co-expressing <italic>NonA</italic> RNAi. This may have caused a dilution effect that led to lower hTDP-43 expression levels. Notably, Elden et al. showed that a YFP fusion of hTDP-43 that has higher steady-state expression led to more severe eye defects. Therefore, it appears that the eye degeneration phenotype is sensitive to hTDP-43 dosage.</p><p id="P22">Similarly, the reduced life span was observed in <italic>elav&gt;hTDP-43</italic> flies in the study by Elden et al., but not in our study. This discrepancy is also likely attributed to differences in experimental conditions, with flies kept at 29°C in Elden et al. and at 25°C in our study. In summary, the effect of genetic manipulation of NONO and TDP-43 on neuropathology is sensitive to the choice of the driver and experimental conditions.</p><p id="P23">Our findings lay the foundation for further investigation into the functional interaction between TDP-43 and NONO. Future studies examining their dynamic subcellular localization in both single and combined mutant genotypes, along with exploring their synergistic effects on neuronal morphology and function, may yield valuable insights.</p></sec></body><back><ack id="S10"><title>Acknowledgments</title><p>We are grateful to Steven Brown for sharing us with unpublished data and contributing to the conceptualization of this project. This study was supported by the grant from the Swiss National Science Foundation to E.N. (310030_189169).</p></ack><sec id="S11" sec-type="data-availability"><title>Data Accessibility</title><p id="P24">All data in this study are displayed in the manuscript.</p></sec><fn-group><fn id="FN1" fn-type="conflict"><p id="P25"><bold>Competing interests</bold></p><p id="P26">The authors declare no competing interests.</p></fn><fn id="FN2" fn-type="con"><p id="P27"><bold>Author contribution</bold></p><p id="P28">E.N. and R.K. conceived the project and planned the experiments. R.K. conducted the experiments and analyzed the data. R.K. and E.N. wrote the manuscript.</p></fn></fn-group><ref-list><ref id="R1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benegiamo</surname><given-names>G</given-names></name><name><surname>Mure</surname><given-names>LS</given-names></name><name><surname>Erikson</surname><given-names>G</given-names></name><name><surname>Le</surname><given-names>HD</given-names></name><name><surname>Moriggi</surname><given-names>E</given-names></name><name><surname>Brown</surname><given-names>SA</given-names></name><name><surname>Panda</surname><given-names>S</given-names></name></person-group><article-title>The RNA-Binding Protein NONO Coordinates Hepatic Adaptation to Feeding</article-title><source>Cell Metab</source><year>2018</year><volume>27</volume><fpage>404</fpage><lpage>418</lpage><elocation-id>e7</elocation-id><pub-id pub-id-type="pmcid">PMC6996513</pub-id><pub-id pub-id-type="pmid">29358041</pub-id><pub-id pub-id-type="doi">10.1016/j.cmet.2017.12.010</pub-id></element-citation></ref><ref id="R2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bou Dib</surname><given-names>P</given-names></name><name><surname>Gnagi</surname><given-names>B</given-names></name><name><surname>Daly</surname><given-names>F</given-names></name><name><surname>Sabado</surname><given-names>V</given-names></name><name><surname>Tas</surname><given-names>D</given-names></name><name><surname>Glauser</surname><given-names>DA</given-names></name><name><surname>Meister</surname><given-names>P</given-names></name><name><surname>Nagoshi</surname><given-names>E</given-names></name></person-group><article-title>A conserved role for p48 homologs in protecting dopaminergic neurons from oxidative stress</article-title><source>PLoS Genet</source><year>2014</year><volume>10</volume><elocation-id>e1004718</elocation-id><pub-id pub-id-type="pmcid">PMC4207665</pub-id><pub-id pub-id-type="pmid">25340742</pub-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1004718</pub-id></element-citation></ref><ref id="R3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>SA</given-names></name><name><surname>Ripperger</surname><given-names>J</given-names></name><name><surname>Kadener</surname><given-names>S</given-names></name><name><surname>Fleury-Olela</surname><given-names>F</given-names></name><name><surname>Vilbois</surname><given-names>F</given-names></name><name><surname>Rosbash</surname><given-names>M</given-names></name><name><surname>Schibler</surname><given-names>U</given-names></name></person-group><article-title>PERIOD1-associated proteins modulate the negative limb of the mammalian circadian oscillator</article-title><source>Science</source><year>2005</year><volume>308</volume><fpage>693</fpage><lpage>696</lpage><pub-id pub-id-type="pmid">15860628</pub-id></element-citation></ref><ref id="R4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buratti</surname><given-names>E</given-names></name><name><surname>Baralle</surname><given-names>FE</given-names></name></person-group><article-title>TDP-43: gumming up neurons through protein-protein and protein-RNA interactions</article-title><source>Trends Biochem Sci</source><year>2012</year><volume>37</volume><fpage>237</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">22534659</pub-id></element-citation></ref><ref id="R5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Boer</surname><given-names>EMJ</given-names></name><name><surname>Orie</surname><given-names>VK</given-names></name><name><surname>Williams</surname><given-names>T</given-names></name><name><surname>Baker</surname><given-names>MR</given-names></name><name><surname>De Oliveira</surname><given-names>HM</given-names></name><name><surname>Polvikoski</surname><given-names>T</given-names></name><name><surname>Silsby</surname><given-names>M</given-names></name><name><surname>Menon</surname><given-names>P</given-names></name><name><surname>van den Bos</surname><given-names>M</given-names></name><name><surname>Halliday</surname><given-names>GM</given-names></name><name><surname>van den Berg</surname><given-names>LH</given-names></name><etal/></person-group><article-title>TDP-43 proteinopathies: a new wave of neurodegenerative diseases</article-title><source>J Neurol Neurosurg Psychiatry</source><year>2021</year><volume>92</volume><fpage>86</fpage><lpage>95</lpage><pub-id pub-id-type="pmcid">PMC7803890</pub-id><pub-id pub-id-type="pmid">33177049</pub-id><pub-id pub-id-type="doi">10.1136/jnnp-2020-322983</pub-id></element-citation></ref><ref id="R6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diaper</surname><given-names>DC</given-names></name><name><surname>Adachi</surname><given-names>Y</given-names></name><name><surname>Sutcliffe</surname><given-names>B</given-names></name><name><surname>Humphrey</surname><given-names>DM</given-names></name><name><surname>Elliott</surname><given-names>CJH</given-names></name><name><surname>Stepto</surname><given-names>A</given-names></name><name><surname>Ludlow</surname><given-names>ZN</given-names></name><name><surname>Vanden Broeck</surname><given-names>L</given-names></name><name><surname>Callaerts</surname><given-names>P</given-names></name><name><surname>Dermaut</surname><given-names>B</given-names></name><name><surname>Al-Chalabi</surname><given-names>A</given-names></name><etal/></person-group><article-title>Loss and gain of Drosophila TDP-43 impair synaptic efficacy and motor control leading to age-related neurodegeneration by loss-of-function phenotypes</article-title><source>Human Molecular Genetics</source><year>2013</year><volume>22</volume><fpage>1539</fpage><lpage>1557</lpage><pub-id pub-id-type="pmcid">PMC3605831</pub-id><pub-id pub-id-type="pmid">23307927</pub-id><pub-id pub-id-type="doi">10.1093/hmg/ddt005</pub-id></element-citation></ref><ref id="R7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dykstra</surname><given-names>M</given-names></name><name><surname>Barmada</surname><given-names>SJ</given-names></name></person-group><article-title>The MLO-down on TDP-43</article-title><source>Brain</source><year>2023</year><volume>146</volume><fpage>3565</fpage><lpage>3567</lpage><pub-id pub-id-type="pmcid">PMC10473555</pub-id><pub-id pub-id-type="pmid">37540028</pub-id><pub-id pub-id-type="doi">10.1093/brain/awad268</pub-id></element-citation></ref><ref id="R8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elden</surname><given-names>AC</given-names></name><name><surname>Kim</surname><given-names>H-J</given-names></name><name><surname>Hart</surname><given-names>MP</given-names></name><name><surname>Chen-Plotkin</surname><given-names>AS</given-names></name><name><surname>Johnson</surname><given-names>BS</given-names></name><name><surname>Fang</surname><given-names>X</given-names></name><name><surname>Armakola</surname><given-names>M</given-names></name><name><surname>Geser</surname><given-names>F</given-names></name><name><surname>Greene</surname><given-names>R</given-names></name><name><surname>Lu</surname><given-names>MM</given-names></name><name><surname>Padmanabhan</surname><given-names>A</given-names></name><etal/></person-group><article-title>Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS</article-title><source>Nature</source><year>2010</year><volume>466</volume><fpage>1069</fpage><lpage>1075</lpage><pub-id pub-id-type="pmcid">PMC2965417</pub-id><pub-id pub-id-type="pmid">20740007</pub-id><pub-id pub-id-type="doi">10.1038/nature09320</pub-id></element-citation></ref><ref id="R9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>AH</given-names></name><name><surname>Nakagawa</surname><given-names>S</given-names></name><name><surname>Hirose</surname><given-names>T</given-names></name><name><surname>Bond</surname><given-names>CS</given-names></name></person-group><article-title>Paraspeckles: Where Long Noncoding RNA Meets Phase Separation</article-title><source>Trends in Biochemical Sciences</source><year>2018</year><volume>43</volume><fpage>124</fpage><lpage>135</lpage><pub-id pub-id-type="pmid">29289458</pub-id></element-citation></ref><ref id="R10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawakami</surname><given-names>I</given-names></name><name><surname>Arai</surname><given-names>T</given-names></name><name><surname>Hasegawa</surname><given-names>M</given-names></name></person-group><article-title>The basis of clinicopathological heterogeneity in TDP-43 proteinopathy</article-title><source>Acta Neuropathol</source><year>2019</year><volume>138</volume><fpage>751</fpage><lpage>770</lpage><pub-id pub-id-type="pmcid">PMC6800885</pub-id><pub-id pub-id-type="pmid">31555895</pub-id><pub-id pub-id-type="doi">10.1007/s00401-019-02077-x</pub-id></element-citation></ref><ref id="R11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kowalska</surname><given-names>E</given-names></name><name><surname>Ripperger</surname><given-names>JA</given-names></name><name><surname>Hoegger</surname><given-names>DC</given-names></name><name><surname>Bruegger</surname><given-names>P</given-names></name><name><surname>Buch</surname><given-names>T</given-names></name><name><surname>Birchler</surname><given-names>T</given-names></name><name><surname>Mueller</surname><given-names>A</given-names></name><name><surname>Albrecht</surname><given-names>U</given-names></name><name><surname>Contaldo</surname><given-names>C</given-names></name><name><surname>Brown</surname><given-names>SA</given-names></name></person-group><article-title>NONO couples the circadian clock to the cell cycle</article-title><source>Proceedings of the National Academy of Sciences</source><year>2013</year><volume>110</volume><fpage>1592</fpage><lpage>1599</lpage><pub-id pub-id-type="pmcid">PMC3562797</pub-id><pub-id pub-id-type="pmid">23267082</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1213317110</pub-id></element-citation></ref><ref id="R12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kozlov</surname><given-names>A</given-names></name><name><surname>Koch</surname><given-names>R</given-names></name><name><surname>Nagoshi</surname><given-names>E</given-names></name></person-group><article-title>Nitric oxide mediates neuro-glial interaction that shapes Drosophila circadian behavior</article-title><source>PLOS Genetics</source><year>2020</year><volume>16</volume><elocation-id>e1008312</elocation-id><pub-id pub-id-type="pmcid">PMC7367490</pub-id><pub-id pub-id-type="pmid">32598344</pub-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1008312</pub-id></element-citation></ref><ref id="R13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Ray</surname><given-names>P</given-names></name><name><surname>Rao</surname><given-names>EJ</given-names></name><name><surname>Shi</surname><given-names>C</given-names></name><name><surname>Guo</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Woodruff</surname><given-names>EA</given-names></name><name><surname>Fushimi</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>JY</given-names></name></person-group><article-title>A Drosophila model for TDP-43 proteinopathy</article-title><source>Proceedings of the National Academy of Sciences</source><year>2010</year><volume>107</volume><fpage>3169</fpage><lpage>3174</lpage><pub-id pub-id-type="pmcid">PMC2840283</pub-id><pub-id pub-id-type="pmid">20133767</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0913602107</pub-id></element-citation></ref><ref id="R14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>W</given-names></name><name><surname>Guo</surname><given-names>F</given-names></name><name><surname>McMahon</surname><given-names>A</given-names></name><name><surname>Couvertier</surname><given-names>S</given-names></name><name><surname>Jin</surname><given-names>H</given-names></name><name><surname>Diaz</surname><given-names>M</given-names></name><name><surname>Fieldsend</surname><given-names>A</given-names></name><name><surname>Weerapana</surname><given-names>E</given-names></name><name><surname>Rosbash</surname><given-names>M</given-names></name></person-group><article-title>NonA and CPX Link the Circadian Clockwork to Locomotor Activity in Drosophila</article-title><source>Neuron</source><year>2018</year><volume>99</volume><fpage>768</fpage><lpage>780</lpage><elocation-id>e3</elocation-id><pub-id pub-id-type="pmcid">PMC6442453</pub-id><pub-id pub-id-type="pmid">30057203</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2018.07.001</pub-id></element-citation></ref><ref id="R15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>M</given-names></name><name><surname>Sampathu</surname><given-names>DM</given-names></name><name><surname>Kwong</surname><given-names>LK</given-names></name><name><surname>Truax</surname><given-names>AC</given-names></name><name><surname>Micsenyi</surname><given-names>MC</given-names></name><name><surname>Chou</surname><given-names>TT</given-names></name><name><surname>Bruce</surname><given-names>J</given-names></name><name><surname>Schuck</surname><given-names>T</given-names></name><name><surname>Grossman</surname><given-names>M</given-names></name><name><surname>Clark</surname><given-names>CM</given-names></name><name><surname>McCluskey</surname><given-names>LF</given-names></name><etal/></person-group><article-title>Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis</article-title><source>Science</source><year>2006</year><volume>314</volume><fpage>130</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">17023659</pub-id></element-citation></ref><ref id="R16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanyal</surname><given-names>S</given-names></name></person-group><article-title>Genomic mapping and expression patterns of C380, OK6 and D42 enhancer trap lines in the larval nervous system of Drosophila</article-title><source>Gene Expression Patterns</source><year>2009</year><volume>9</volume><fpage>371</fpage><lpage>380</lpage><pub-id pub-id-type="pmid">19602393</pub-id></element-citation></ref><ref id="R17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanewsky</surname><given-names>R</given-names></name><name><surname>Rendahl</surname><given-names>KG</given-names></name><name><surname>Dill</surname><given-names>M</given-names></name><name><surname>Saumweber</surname><given-names>H</given-names></name></person-group><article-title>Genetic and molecular analysis of the X chromosomal region 14B17-14C4 in Drosophila melanogaster: loss of function in NONA, a nuclear protein common to many cell types, results in specific physiological and behavioral defects</article-title><source>Genetics</source><year>1993</year><volume>135</volume><fpage>419</fpage><lpage>442</lpage><pub-id pub-id-type="pmcid">PMC1205646</pub-id><pub-id pub-id-type="pmid">8244005</pub-id><pub-id pub-id-type="doi">10.1093/genetics/135.2.419</pub-id></element-citation></ref><ref id="R18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Duan</surname><given-names>Y</given-names></name><name><surname>Duan</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Deng</surname><given-names>X</given-names></name><name><surname>Qian</surname><given-names>B</given-names></name><name><surname>Gu</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>L</given-names></name><etal/></person-group><article-title>Stress Induces Dynamic, Cytotoxicity-Antagonizing TDP-43 Nuclear Bodies via Paraspeckle LncRNA NEAT1-Mediated Liquid-Liquid Phase Separation</article-title><source>Molecular Cell</source><year>2020</year><volume>79</volume><fpage>443</fpage><lpage>458</lpage><elocation-id>e7</elocation-id><pub-id pub-id-type="pmid">32649883</pub-id></element-citation></ref><ref id="R19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>L-L</given-names></name></person-group><article-title>Organization and function of paraspeckles</article-title><source>Essays in Biochemistry</source><year>2020</year><volume>64</volume><fpage>875</fpage><lpage>882</lpage><pub-id pub-id-type="pmid">32830222</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>Knockdown of <italic>nonA</italic> in motor neurons exacerbates the locomotor deficits resulting from the overexpression of <italic>hTDP-43</italic>.</title><p>Climbing ability was assessed in flies expressing <italic>hTDP-43</italic> or <italic>nonA</italic> RNAi from <italic>D42-GAL4</italic> independently or in combination, along with the control flies carrying only the GAL4 driver or <italic>UAS-hTDP-43</italic>, between age day 1 to 21. <italic>UAS-mCD8::GFP</italic> (GFP) was co-expressed when only one of the UAS transgenes was driven. Each dot represents the climbing ability of a group of ~20 males of indicated genotypes. N=5 independent experiments. The numbers of flies on day 1 were: <italic>UAS-hTDP-43</italic> (100), <italic>D42&gt;hTDP-43, GFP</italic> (97), <italic>D42&gt;RNAi 1, GFP</italic> (108), <italic>D42&gt;RNAi 1, hTDP-43</italic> (74), and <italic>D42&gt;RNAi 2, GFP</italic> (20). All three repeats per day are shown. <italic>D42&gt;RNAi 2</italic> was semi-lethal and the limited number of individuals obtained could be tested on day 1 only (N=1). Different letters indicate significant differences between groups (p&lt;0.05, one-way ANOVA with Tukey’s post-hoc test for multiple comparisons).</p></caption><graphic xlink:href="EMS192792-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>Overexpression of <italic>hTDP-43</italic> exacerbates the reduced lifespan resulting from <italic>nonA</italic> loss of function.</title><p><italic>UAS-nonA RNAi</italic> and <italic>hTDP-43</italic> were driven with a pan-neuronal <italic>elav-GAL4</italic>, individually or in combination. Lifespans of male flies of 5 to 6 independent replicates indicated genotypes were assessed at 25°C. The numbers of flies were: <italic>elav-Gal4</italic> (119), <italic>UAS-hTDP-43</italic> (125), <italic>UAS-RNAi 1</italic> (114), <italic>UAS-RNAi 2</italic> (106), <italic>elav&gt;hTDP-43, GFP</italic> (95), <italic>elav&gt;RNAi 1, GFP</italic> (49), <italic>elav&gt;RNAi 1, GFP</italic> (101), <italic>elav&gt;RNAi1, hTDP-43</italic> (101), and <italic>elav&gt;RNAi 2, hTDP-43</italic> (102). Controls are plotted in dotted lines. ns, not significant. *<italic>p</italic>&lt;0.05, **<italic>p</italic>&lt;0.01, ***<italic>p</italic>&lt;0.001 and ****<italic>p</italic>&lt;0.0001 (Kaplan-Meier estimator).</p></caption><graphic xlink:href="EMS192792-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>Expression of <italic>nonA</italic> RNAi or <italic>hTDP-43</italic> did not induce discernible eye defects.</title><p><italic>UAS-nonA RNAi</italic> and <italic>hTDP-43</italic>, either alone or in combination, were driven by <italic>GMR-GAL4</italic>. Eye morphology of 7-day-old adults was examined, revealing no ommatidial or necrotic defects. Representative images are shown.</p></caption><graphic xlink:href="EMS192792-f003"/></fig></floats-group></article>